4Arrowsmith JE, Campbell SF, Cross PE, et al. Long - acting dihy- dropyri - dinE calcium antagonists. 1,2 - Alkoxymethyl deriva- tives incorpo- rating basic substituents[ J ]. J Med Chem, 1986, 29 (9) : 1696-1702.
5Sepracor专利文献w0/[P].1993/010779.
6Willenheimer R, Dahlof B, Rydberg E, et al. AT1 - receptor blockers inhypertension and heart failure:clinical experience and future direc - tions [ J ]. Eur Heart J, 1999,20 ( 14 ) : 997-1008.
7Kjeldsen SE, Dahlof B, Devereux RB, et al. Effects of losartan on idity and mortality in patients with isolated systolic hypertension and leftventricular hypertrophy. A Losartan Intervention for Endpoint Reduction ( LIFE ) substudy [ J ]. JA- MA,2002,288 (12) : 1491-1498.
8Miao CY, Xie HH, Wang JJ, Su DF. Candesartan inhibits sinoaor- ticdenervation - induced cardiovascular hypertrophy in rats [ J ]. Acta Pharmacol Sin,2002,23 ( 8 ) :713-20.
10Mallion JM, Siche JP, Baguet JP, et al. Various approaches to e - valuating the kinetics and efficacy of three antihypertensive drug- sin terms of variations in blood pressure and heart rate [ J ]. BloodPress Monit, 1998,3 ( 3 ) : 189-194.
